Table 2.
Characteristics of the 5 cases diagnosed with breast cancer during the surveillance period
| Patient no. | Age at breast cancer diagnosis (years) | Mutation | Surveillance period (months) | Diagnostic modality | Family history | Pathology | Stage | Outcome |
|---|---|---|---|---|---|---|---|---|
| 1 | 42 | BRCA1 | 4 | MMG | BC | DCIS |
TisN0M0 Stage 0 |
Alive without metastasis |
| 2 | 35 | BRCA1 | 145 | MRI | BC+OC | DCIS |
TisN0M0 Stage 0 |
Alive without metastasis |
| 3 | 47 | BRCA2 | 7 | US | BC | IDC |
T1N0M0 StageI |
Alive without metastasis |
| 4 | 48 | BRCA2 | 51 | MRI | BC | DCIS |
TisN0M0 Stage 0 |
Alive without metastasis |
| 5 | 35 | BRCA2 | 35 | CE (self-palpation) | BC+OC | IDC |
T2N1M0 Stage IIB |
Alive without metastasis |
MMG mammography, US ultrasonography, MRI magnetic resonance imaging, CE clinical examination, BC breast cancer, OC ovarian cancer